Sample: urine
 
Description
The GPL-MycoTOX is a comprehensive mycotoxin test that screens for eleven mycotoxins and forty species of mould from a single urine sample.

Mycotoxins (toxins from mould) are some of the most prevalent toxins in the environment. Mycotoxins are metabolites produced by fungi like mould, which can infest buildings, vehicles, and foodstuffs. Most mycotoxin exposures in North America, Europe, and Australia are through airborne exposure. Food may be a major source of mycotoxins in third-world nations that lack government inspection of foods, especially the grains such as rice, corn, wheat, rye, and barley. Many grains that are harvested have been found to be contaminated with mycotoxins but little of such harvests are discarded and are frequently sold for animal feeds such as dog food or feed for cows, pigs, chickens, turkeys, and horses.
Fungi can grow on almost any surface, especially if the environment is warm and wet. Inner wall materials of buildings, wallpaper, fibre glass insulation, ceiling tiles, and gypsum support are all good surfaces for fungi to colonise. These fungi then release mycotoxins into the environment causing symptoms of many different chronic diseases. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. With the MycoTOX Profile, GPL says that you can identify mycotoxin exposures and make recommendations for detoxification treatments that have been effective.
 
Methodology
Mycotoxins are measured using state-of-the-art liquid chromatography-mass spectrometry (LC-MS/MS) technology. Using this technology, they have a very sensitive test, which is important because mycotoxins can cause serious health issues even in small quantities.
This mycotoxin test is corrected for differences in fluid intake using the technique called creatinine correction. Failure to use creatinine correction can lead to a thirty-fold variation in the concentration of the mycotoxins when there is variation in fluid intake. Utilization of LC-MS/MS technology gives us a precise identification of all our analytes, which prevents having false-positive errors. For many of their compounds they can detect amounts in the parts per trillion (ppt) which is about 100-fold better than any other test currently available.

Analytes
Aflatoxin M1 (AFM1)
Ochratoxin A (OTA)
Sterigmatocystin (STG)
Roridin E
Verrucarin A
Enniatin B1
Zearalenone (ZEA)
Gliotoxin (GTX)
Dihdrocitrinone Citrinin (DHC)
Chaetoglobosin A
 
When should I use
Neurological conditions such autism, Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, nose bleeding, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. A study of patients with chronic fatigue found that all the patients had high levels of mycotoxins in the urine.
 
Analytes
Aflatoxin M1 (AFM1)
Chaetoglobosin A
Citrinin
Enniatin B
Gliotoxin
Mycophenolic Acid
Ochratoxin A (OTA)
Roridin E
Sterigmatocystin (STG)
Verrucarin A
Zearalenone (ZEA)